A telephone replay will be available beginning approximately two hours after the call through July 22, 2008, and may be accessed by dialing (800) 633-8284 from the United States and Canada or (+1 402) 977-9140 internationally. The replay passcode is 21388502. An archived replay of the web cast will be available until the next quarterly call.
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at http://www.vermillion.com.
Forward Looking Statements
This news release contains forward-looking statements that involve
significant risks and uncertainties, including the risks and uncertainties
discussed in Vermillion's Form 10-K for the year ended December 31, 2007,
and Vermillion's periodic reports on Form 10-Q and Form 8-K. Vermillion is
providing this information as of the date of this news release and does not
undertake any obligation to update any forward-looking statements as a
result of new information, future events or otherwise. Forward-looking
statements cannot be guaranteed and actual
|SOURCE Vermillion, Inc.|
Copyright©2008 PR Newswire.
All rights reserved